TScan Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $272.1M
Liabilities Breakdown FY2023
Total Liabilities: $121.3M
Asset Breakdown
Total Assets: $272.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $133.4M | 49.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.7M | 2.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $131.0M | 48.2% |
Liabilities Breakdown
Total Liabilities: $121.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.4M | 2.0% |
| Long-Term Debt | $26.7M | 22.0% |
| Other Liabilities | $92.2M | 76.0% |